((SL Advertiser)) To learn more about Axonics Therapy and Urologic Surgeons of Arizona call 480-409-5060 or visit ...

A global medical device company awarded its highest honor to the Urology Department at Horizon Health. Axonics presented its ...

Axonics announced today that it received regulatory approval in Australia for its R20 rechargeable sacral neuromodulation ...

With the advancement in endoscopic surgery, radiation treatment planning and execution, as well as the use of new chemotherapeutic regimens, bladder conservation has evolved into a competing ...

Medical device maker Axonics has convinced a jury in California federal court that it did not violate rival Medtronic's ...

Axonics® sacral neuromodulation systems provide adults with overactive bladder and/or fecal incontinence with long-lived, easy to use, safe, clinically effective therapy. In addition, the company ...

Axonics, Inc. AXNX has received regulatory approval from the Therapeutic Goods Administration (TGA) to market its R20 rechargeable sacral neuromodulation (SNM) system in Australia. This cutting ...

“Approval of the Axonics R20 is welcome news for Australians with bladder and bowel dysfunction,” said Dr. Janelle Brennan, a urologist at St. John of God Bendigo Hospital. “I am ...